Off-Label Use in Europe
Special issues in Europe: National rules regarding authorisation and reimbursement of off-label use
-
Special issues in Europe: National rules regarding authorisation and reimbursement of off-label use51.218714 6.777493
Wann |
22.11.2017 von 09:00 bis 17:00 |
---|---|
Veranstaltungsort | Düsseldorf, Leonardo Royal Hotel Düsseldorf Königsallee |
Stadt | Düsseldorf |
Kontaktname | Jessica Jegodka |
Kontakttelefon | +49 6221 500-696 |
Zielgruppe |
This seminar will be of benefit to all those working in the pharmaceutical ndustry who need an in-depth understanding of the current off-label use regulation in Europe and the opportunities and risks of off-label use. Those working in -Medical Affairs -Pharmacovigilance -Marketing/Sales -Law will especially profit from the seminar. |
Termin übernehmen |
vCal iCal |
This seminar addresses the different legal situations and the handling of off-label use in Europe. National course of action and the consequences for EU harmonisation will be particularly discussed.
Our experts will provide detailed information on the following areas of conflict: medical affairs, sales, pharmacovigilance, legal, insurance and clinical.
After the seminar you will be aware of the difference between advertising, information and pre-approval information for off-label use, how to get knowledge of off-label use and how to handle it. You will know who is liable in cases of damage and how to minimise the risk. Moreover you will understand the regulations for health insurance companies regarding off-label use promotion and reimbursement.
Our experts will provide detailed information on the following areas of conflict: medical affairs, sales, pharmacovigilance, legal, insurance and clinical.
After the seminar you will be aware of the difference between advertising, information and pre-approval information for off-label use, how to get knowledge of off-label use and how to handle it. You will know who is liable in cases of damage and how to minimise the risk. Moreover you will understand the regulations for health insurance companies regarding off-label use promotion and reimbursement.
Themen der Veranstaltung:
- Areas of conflict: medical affairs - sales pharmacovigilance - legal - insurance
- Advertising vs. information - what is possible?
- Event of damage: consequences and course of action
- Off-label use and healthcare cost controls: EU principles and national examples
- Advertising vs. information - what is possible?
- Event of damage: consequences and course of action
- Off-label use and healthcare cost controls: EU principles and national examples
Weitere Informationen über diesen Termin…
FORUM Institut für Management GmbH